Summit Investment Advisors »

Madrigal Pharmaceuticals shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $355k 1.5k 231.38
2023-09-30 $198k 1.4k 146.04
2023-06-30 $260k 1.1k 231.00
2023-03-31 $240k 990 242.26
2022-12-31 $287k 940 304.94
2022-09-30 $57k 890 64.04
2022-06-30 $63k 890 70.79
2022-03-31 $87k 890 97.75
2021-12-31 $75k 890 84.27
2021-09-30 $71k 890 79.78
2021-06-30 $87k 890 97.75
2021-03-31 $92k 787 116.90
2020-12-31 $87k 787 110.55
2020-09-30 $93k 787 118.17
2020-06-30 $89k 787 113.09
2020-03-31 $46k 687 66.96
2019-12-31 $63k 687 91.70
2019-09-30 $52k 598 86.96
2019-06-30 $63k 598 105.35
2019-03-31 $75k 598 125.42
2018-12-31 $67k 598 112.04
2018-09-30 $128k 598 214.05
2018-06-30 $143k 512 279.30
2018-03-31 $41k 355 115.49
2017-12-31 $33k 355 92.96
2017-09-30 $6.0k 355 16.90
2017-06-30 $6.0k 355 16.90